interesting about China and Recell. IMHO the big driver of sales going forward is the US with more burn centres coming on board every month. Based on last Q report might expect another small uptick in RoW sales. Will look for commentary on China sales. We shall find out soon enough in FYQ3 report. if advertisincg big in China lets see how it translates to sales. all potential though. I note that the ReCell trials for Juvenile Burns are not scheduled to finish until Dec 2019. Not sure ot imeline to get FDA approval but that will be another pipeline of sales in due course. Happy Days.
AVMXY, page-134
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |